EurekAlert! Cancer Research - News Releases

News Releases

Updates every hour. Last Updated: 25-Jun-2026 23:16 ET (26-Jun-2026 03:16 GMT/UTC)

New analytical method reveals how drug combinations act in leukemia – study opens the door to precision designed combinatorial therapies

Tampere University
Peer-Reviewed Publication

Acute myeloid leukemia (AML) remains one of the most difficult blood cancers to treat. Although drug combinations are often more effective than single agents, their true mechanisms of action have been poorly understood. A new study introduces CoPISA – the Combinatorial Proteome Integral Solubility/Stability Alteration analysis, a powerful high‑throughput proteomics workflow that uncovers how drug combinations reshape the soluble proteome in ways that single drugs cannot.

Journal: Nature Communications

OHSU study uncovers internal cell ‘trade winds’ that drive movement and repair

Oregon Health & Science University
Peer-Reviewed Publication

Scientists at Oregon Health & Science University have uncovered a previously unknown system of internal “trade winds” that help cells rapidly move essential proteins to the front of the cell, reshaping how researchers understand cell migration, cancer spread and wound healing.

The discovery, published today in Nature Communications, reshapes what researchers thought they knew about how cells direct proteins to the right place at the right time.

Journal: Nature Communications
Funder: W. M. Keck Foundation, Howard Hughes Medical Institute

HKUMed discovers expanded use of fatty liver drug for preventing and suppressing liver cancer

The University of Hong Kong
Peer-Reviewed Publication

A research team from the Department of Pathology, School of Clinical Medicine, LKS Faculty of Medicine of the University of Hong Kong (HKUMed), in collaboration with the HKU State Key Laboratory of Liver Research, has found that Resmetirom, a drug approved by the U.S. Food and Drug Administration (FDA) for treating metabolic dysfunction-associated fatty liver disease (MAFLD), demonstrates benefits beyond reducing liver fat and fibrosis. The study shows that the drug also has potential to prevent and suppress liver cancer caused by fatty liver disease. The findings were published in the international journal Hepatology.

Journal: Hepatology

Lisa G. Roth, MD, named director of pediatric hematology-oncology at Hassenfeld Children’s Hospital at NYU Langone

NYU Langone Health / NYU Grossman School of Medicine
Business Announcement

“My own experience as a cancer patient reinforced how important it is to care for the whole person, not just the disease,” said Dr. Roth.

University of Maryland Greenebaum Comprehensive Cancer Center receives $3 million NCI Award to develop next generation of cancer researchers

University of Maryland School of Medicine
Grant and Award Announcement

The University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center (UMGCCC) has been awarded a prestigious $3 million National Cancer Institute (NCI) Career Development Award to train the next generation of oncology researchers focused on treating patients of all backgrounds.

UNC researchers publish findings in JAMA Network Open about impact of diagnostic wait time on ovarian cancer survival

UNC Gillings School of Global Public Health
Peer-Reviewed Publication

The study "Diagnostic Timing and Ovarian Cancer Survival in North Carolina" has been published in the latest issue of JAMA Network Open. Led by a team of UNC researchers, this study explored the relationship between survival and how quickly patients are diagnosed with ovarian cancer.

Journal: JAMA Network Open

Lasting income costs of mental and physical illness

JAMA Network
Peer-Reviewed Publication

About The Study: This study estimated income losses from the individual perspective in the 10 years following hospital diagnosis of depression, alcohol use disorder, stroke, and breast cancer from 2000 to 2023 in Denmark. The researchers found that (1) income losses following mental disorder diagnoses were larger than those for physical conditions, though all evaluated diseases led to substantive loss; (2) average losses grew in years following diagnosis, particularly among individuals younger than 40 and those in school, suggesting accumulating disadvantage; and (3) even those outside of the workforce at the time of hospital diagnosis experienced sustained future income loss.

Journal: JAMA Health Forum

Artificial intelligence learns to make sense of childhood cancer survivors’ health care needs

St. Jude Children's Research Hospital
Peer-Reviewed Publication

St. Jude Children’s Research Hospital scientists studied how prompting styles influence artificial intelligence’s ability to analyze interviews and identify childhood cancer survivors needing extra support.

Journal: Communications Medicine

MSK Research Highlights, March 27, 2026

Memorial Sloan Kettering Cancer Center
Peer-Reviewed Publication

New research from Memorial Sloan Kettering Cancer Center (MSK) finds skin stem cells retain long-lasting memory of inflammation; shows how a large cancer DNA study could transform personalized oncology; reveals how the protein BAF helps cancer cells hide from the immune system; and investigates how early DNA markings shape cell fate.

Molecular test doubles detection of bile duct cancer

University of Pittsburgh
Peer-Reviewed Publication

Scientists at UPMC Hillman Cancer Center and the University of Pittsburgh School of Medicine developed BiliSeq, a molecular test that detected bile duct cancer with twice the sensitivity of the standard test, giving physicians a more accurate picture of the patient’s diagnosis.

Journal: Gastroenterology
Funder: National Pancreas Foundation, Sky Foundation, Pancreatic Cancer Action Network